Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. APUS
APUS logo

APUS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

APUS News

Apimeds Reaches Settlement with Inscobee, Clearing Path for Merger

4d agoNASDAQ.COM

Apimeds Pharmaceuticals Settles Disputes with Inscobee, Resuming Trading

5d agoNewsfilter

APIMEDS PHARMACEUTICALS US INC ANNOUNCES SETTLEMENT AGREEMENT WITH INSCOBEE DATED APRIL 24, 2026 - SEC FILING

May 04 2026moomoo

Schall Law Firm Investigates Apimeds for Securities Violations

Apr 27 2026Globenewswire

Inscobee Rejects Allegations from MindWave Innovations, Inc.

Mar 25 2026Newsfilter

APIMEDS Pharmaceuticals US Inc. Names Youngjik Cho as CEO and Junyoung Yu as Secretary, Effective Immediately - SEC Filing

Mar 25 2026moomoo

APIMEDS Pharmaceuticals US Inc. Terminates Dr. Vin Menon as CEO, Effective Immediately - SEC Filing

Mar 25 2026moomoo

APIMEDS PHARMACEUTICALS (NOT 'APIMEDS KOREA') NAMES YOUNGJIK CHO AS BOARD CHAIRMAN - SEC FILING

Mar 25 2026moomoo

APIMEDS KOREA NAMES MR. CHO AS BOARD CHAIRMAN IN SEC FILING

Mar 25 2026moomoo

APIMEDS PHARMACEUTICALS REMOVES ELONA KOGAN, JAKAP KOO, CAROL O'DONNELL, AND BENNETT WEINTRAUB FROM BOARD OF DIRECTORS EFFECTIVE IMMEDIATELY, ACCORDING TO SEC FILING DATED MARCH 20

Mar 25 2026moomoo

MindWave Faces Hostile Takeover Attempt by Inscobee

Mar 24 2026Newsfilter

Apimeds and Lōkahi Secure FDA Meeting Confirmation for LT-100

Feb 11 2026Newsfilter

Three Small IPOs Set to Raise $46 Million Next Week

Dec 23 2025renaissancecapital

E.F. Hutton Facilitates APUS and Mindwave Merger with $100 Million PIPE Financing

Dec 17 2025Globenewswire

E.F. Hutton Facilitates $100M Merger Between Apimeds and Mindwave Innovations

Dec 17 2025Newsfilter

Apimeds Closes $100 Million PIPE Financing to Advance Non-Opioid Therapies

Dec 10 2025Newsfilter